HYQVIA
STN: BL 125402/0
Proper Name: Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase
Tradename: HYQVIA
Manufacturer: Baxalta US Inc.
Indication:
- Indicated for the treatment of Primary Immunodeficiency (PI) in adults and pediatric patients two years of age and older.
Product Information
Supporting Documents
- April 7, 2023 Approval Letter - HYQVIA
- April 7, 2023 Clinical Review Memo - HYQVIA
- April 7, 2023 Statistical Review Memo - HYQVIA
- Approval History, Letters, Reviews, and Related Documents - Hyqvia
- Supporting Documents older than three years - Hyqvia